Cogent Biosciences, Inc. (COGT)

NASDAQ: COGT · Real-Time Price · USD

36.85

-0.55 (-1.47%)

At close: Aug 19, 2026, 4:00 PM EDT

36.65

-0.20 (-0.54%)

Pre-market: Aug 20, 2026, 8:23 AM EDT

Cogent Biosciences Income Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Selling, General & Admin	98.37	63.58	43.28	34.38	26.21	19.64
Research & Development	290.72	269.78	232.66	173.76	121.63	55.91
Operating Expenses	389.09	333.36	275.94	208.13	147.84	75.55
Operating Income	-389.09	-333.36	-275.94	-208.13	-147.84	-75.55
Interest Expense	-5.18	-3.06	-	-	-	-
Interest & Investment Income	24.43	14.69	18.09	13.08	3.99	0.47
Other Non Operating Income (Expenses)	-0.16	-0.02	1.99	2.64	3.61	2.81
EBT Excluding Unusual Items	-370	-321.76	-255.86	-192.41	-140.24	-72.27
Other Unusual Items	-7.18	-7.18	-	-	-	-
Pretax Income	-377.18	-328.94	-255.86	-192.41	-140.24	-72.27
Earnings From Continuing Operations	-	-328.94	-255.86	-192.41	-140.24	-72.27
Net Income	-377.18	-328.94	-255.86	-192.41	-140.24	-72.27
Net Income to Common	-377.18	-328.94	-255.86	-192.41	-140.24	-72.27
Net Income Growth	-	-	-	-	-	-
Shares Outstanding (Basic)	155	129	104	80	59	39
Shares Outstanding (Diluted)	155	129	104	80	59	39
Shares Change	37.58%	24.09%	30.48%	35.41%	51.89%	249.52%
EPS (Basic)	-2.43	-2.55	-2.46	-2.42	-2.38	-1.87
EPS (Diluted)	-2.43	-2.55	-2.46	-2.42	-2.38	-1.87
EPS Growth	-	-	-	-	-	-
Free Cash Flow	-309.24	-266	-208.36	-156.42	-125.5	-60.48
Free Cash Flow Per Share	-2.00	-2.06	-2.00	-1.96	-2.13	-1.56
EBITDA	-386.46	-330.8	-273.49	-205.86	-147	-75.4
D&A For EBITDA	2.64	2.56	2.45	2.27	0.84	0.15
EBIT	-389.09	-333.36	-275.94	-208.13	-147.84	-75.55

SEC Filings: 10-K · 10-Q